Contact this trialFirst, we need to learn more about you.
Gene Therapy
ALS20 for Beta Thalassemia
Recruiting1 awardPhase 1 & 2
Philadelphia, Pennsylvania
This trial aims to investigate whether a new treatment method can safely help patients with a blood disorder called transfusion-dependent beta thalassemia. The treatment involves modifying blood stem cells by adding a healthy
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.